Abstract
There is no doubt that the last decade has witnessed an incredible improvement in the treatment of neoplastic diseases. This is true of not only primary treatment of tumors but also supportive care of patients. In this setting, however, infections remain a major problem because of their significant morbidity and mortality, as well as the impediment they frequently pose to the accomplishment of the antineoplastic therapy.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Preview
Unable to display preview. Download preview PDF.
References
EORTC-International Antimicrobial Therapy Cooperative Group (1986) Empiric therapy in febrile neutropenic patients: different responses in children and adults (abstract). 26th Interscience conference on antimicrobial agents and chemotherapy, New Orleans, September 28–October 1, 681
Cooper RG, Sumner C (1970) Hospital infection data from a children’s hospital. Med J Aust 2: 1110–1113
Bodey GP, Buckley M, Sathe JS, Freireich EJ (1966) Quantitative relationships between circulating leucocytes and infection in patients with acute leukemia. Ann Intern Med 64: 328–340
Ziegler EF, McCutchan JA, Fierer JA (1982) Treatment of Gram-negative bacteremia and shock with human antiserum to a mutant Escherichia coli. N Engl J Med 307: 1225–1230
Peter G, Pizzo PA, Robichaud KJ, Visconts ER, Farman EN, Zinna SH (1979) Possible protective effect of circulatory antibodies to the shared care glycolipid of Enterobacteriaceae in children with malignancy (abstract). Soc Pediat Res 13: 466
Schimpff SC, Young VM, Greene WH, Vermeulen GD, Moody MK, Wiernik PN (1972) Origin of infection in acute non-lymphocytic leukemia: significance of hospital acquisition of potential pathogens. Ann Intern Med 77: 704–714
Schimpff SC, Greene WH, Young VM et al. (1974) Significance of Pseudomonas aeruginosa in the patient with leukemia or lymphoma. J Infect Dis 130: 24–31
Kurrle E, Bhaduri S, Krieger D et al. (1981) Risk factors for infections of the oropharynx and the respiratory tract in patients with acute leukemia. J Infect Dis 144: 128–136
Kingston JE, Fowler PC, Jackson DB, Potter V, Malpas JS (1985) Experience with central intravenous catheter in a pediatric oncology unit. Eur Pediatr Hematol Oncol 2: 29–34
Pizzo PA (1981) Infectious complications in the child with cancer. I. Pathophysiology of the compromised host and the initial evaluation and management of the febrile cancer patient. J Pediatr 98: 341–354
EORTC International Antimicrobial Therapy Project Group (1978) Three antibiotic regimens in the treatment of infections in febrile granulocytopenic patients with cancer. J Infect Dis 137: 14–29
Pizzo PA, Commers J, Cotton D, Gress J, Hathorn J, Hiemenz J, Longo D, Marshall D, Robichaud KD (1984) Approaching the controversies in antibacterial management of cancer patients. Am J Med 76: 436–449
Abraham JL, Mullen JL (1982) A prospective study of prolonged central venous access in leukemia. JAMA 248: 2868–2873
Prince A, Heller B, Levy J, Heird W (1986) Management of fever in patients with central vein catheters. Pediatr Infect Dis 5: 20–24
Hiemenz J, Skelton J, Pizzo P (1986) Perspective on the management of catheter-related infections in cancer patients. Pediatr Infect Dis 5: 6–11
Pizzo P, Ladisch S, Simon RM, Gill F, Levine AS (1978) Increasing incidence of Gram-positive sepsis in cancer patients. Med Pediatr Oncol 5: 241–244
Viscoli C, Perlino GF, De Bernardi B, Fabbri A, Massimo L, Terragna A (1985) Infections in children with cancer. Ital J Pediatr 11: 37–43
Viscoli C, Perlin GF, Moroni C, Ferrea G, Fabbri A, Haupt R, Massimo L, Terragna A (1984) Gram-positive infections in pediatric cancer patients (abstract). 3rd International symposium on infections in the immunocompromised host, Toronto, June 24–28: 136
Wade JC, Schimpff SC, Newman KA, Wiernik PH (1982) Staphylococcus epidermidis: an increasing cause of infection in patients with granulocytopenia. Ann Intern Med 97: 503–508
EORTC International Antimicrobial Therapy Project Group (1983) Combination of amikacin and carbenicillin with or without cefazolin as empirical treatment of febrile neutropenic patients. J Clin Oncol 1: 597–603
EORTC International Antimicrobial Therapy Project Group (1986) Prospective randomized comparison of three antibiotic regimens for empirical bacteremic infections in febrile granulocytopenic patients. Antimicrob Agents Chemother 29: 263–270
Klastersky J (1986) Concept of empiric therapy with antibiotic combinations: indications and limits. Am J Med 80 [suppl 5 c]: 2–12
EORTC International Antimicrobial Therapy Cooperative Group (1986) Gram-positive septicemias in cancer patients (abstract). 26th Interscience conference on antimicrobial agents and chemotherapy, New Orleans, September 28–October 1: 679
Kosmidis HV, Lusher JM, Shope TC, Ravindranath Y, Dajani AS (1980) Infections in leukemic children: a prospective analysis. J Pediatr 96: 814–819
Nachman JB, Honig GR (1980) Fever and neutropenia in children with neoplastic disease. An analysis of 158 episodes. Cancer 45: 407–412
Pizzo PA, Robichaud KJ, Wesley R, Commers JR (1982) Fever in the pediatric and young adult patient with cancer. A prospective study of 1001 episodes. Medicine 61: 153–165
Viscoli C, Moroni C, Garaventa A, Dini G, Mori P, Ferrea G, Massimo L, Terragna A (1986) Ceftazidime amikacin versus ceftazidime + vancomycin as initial empiric treatment of febrile episodes in neutropenic children (abstract). 4th International symposium on infections in the immunocompromised Host, Ronneby Brunn ( Sweden ), June 15–19: 120
Sorrell TC, Packman DR, Shanker S, Foldes M, Munzo R (1982) Vancomycin therapy for methicillin resistant Staphylococcus aureus. Ann Intern Med 97: 344–350
Jadeja L, Bolivar R, Fainstein V, Keating M, McCredie K, Hay M, Bodey G (1984) Piperacillin plus vancomycin in the therapy of febrile episodes in cancer patients. Antimicrob Agents Chemother 26: 295–299
Karp J, Dick J, Angelopulos C, Charache P, Greene L, Burke P, Saral R (1986) Empiric use of vancomycin during prolonged treatment induced granulocytopenia. Randomized, double blind, placebo-controlled clinical trial in patients with acute leukemia. Am J Med 81: 237–242
Morgan G, Duerden BI, Lilleyman JS (1983) Ceftazidime as a single agent in the management of children with fever and neutropenia. J Antimicrob Chemother 12 [suppl A]: 347–351
Fainstein V, Bodey G, Elting L et al. (1983) A randomized study of ceftazidime corn-pared to ceftazidime and tobramycin for the treatment of infections in cancer patients. J Antimicrob Chemother 12 [suppl A]: 101–110
Donnelly JP, Marcus RE, Goldman JM, Cohen J, Worsley AM, Catovsky D, Darrel JH, Want SV, Jalton JAD (1985) Ceftazidime as first line therapy for fever in acute leukemia. J Infect 11: 205–215
Pizzo PA, Hathorn JW, Hiemenz J, Browne M, Commers J, Cotton D, Gress J, Longo D, Marshall D, McKnight J, Rubin M, Skelton J, Thaler M, Wesley R (1986) A randomized trial comparing ceftazidime alone with combination antibiotic therapy in cancer patients with fever and neutropenia. N Engl J Med 315: 552–558
EORTC International Antimicrobial Therapy Cooperative Group (1986) Amikacin short or full course plus ceftazidime versus amikacin plus azlocillin for Gram-negative rod bacteremia in granulocytopenic cancer patients (abstract). 26th Interscience conference on antimicrobial agents and chemotherapy, New Orleans, September 28–October 1: 247
Author information
Authors and Affiliations
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 1988 Springer-Verlag Berlin·Heidelberg
About this paper
Cite this paper
Viscoli, C. (1988). Aspects of Infections in Children with Cancer. In: Senn, HJ., Glaus, A., Schmid, L. (eds) Supportive Care in Cancer Patients. Recent Results in Cancer Research, vol 108. Springer, Berlin, Heidelberg. https://doi.org/10.1007/978-3-642-82932-1_10
Download citation
DOI: https://doi.org/10.1007/978-3-642-82932-1_10
Publisher Name: Springer, Berlin, Heidelberg
Print ISBN: 978-3-642-82934-5
Online ISBN: 978-3-642-82932-1
eBook Packages: Springer Book Archive